PDF Publication Title:
Text from PDF Page: 024
Nanomaterials 2018, 8, 681 24 of 25 227. Sung, A.Y.; Kim, T.-H. Physical properties of ophthalmic hydrogel polymer containing zinc oxide nanoparticles. J. Chosun Nat. Sci. 2013, 6, 76–81. [CrossRef] 228. Söderstjerna, E.; Bauer, P.; Cedervall, T.; Abdshill, H.; Johansson, F.; Johansson, U.E. Silver and gold nanoparticles exposure to in vitro cultured retina—Studies on nanoparticle internalization, apoptosis, oxidative stress, glial- and microglial activity. PLoS ONE 2014, 9, e105359. [CrossRef] [PubMed] 229. Weng,Y.;Liu,J.;Jin,S.;Guo,W.;Liang,X.;Hu,Z.Nanotechnology-basedstrategiesfortreatmentofocular disease. Acta Pharm. Sin. B 2017, 7, 281–291. [CrossRef] [PubMed] 230. Yee, W.; Selvaduray, G.; Hawkins, B. Characterization of silver nanoparticle-infused tissue adhesive for ophthalmic use. J. Mech. Behav. Biomed. Mater. 2016, 55, 67–74. [CrossRef] [PubMed] 231. Rizzello,L.;Pompa,P.P.Nanosilver-basedantibacterialdrugsanddevices:Mechanisms,methodological drawbacks, and guidelines. Chem. Soc. Rev. 2014, 43, 1501–1518. [CrossRef] [PubMed] 232. Pind’áková,L.;Kašpárková,V.;Kejlová,K.;Dvorˇáková,M.;Krsek,D.;Jírová,D.;Kašparová,L.Behaviourof silver nanoparticles in simulated saliva and gastrointestinal fluids. Int. J. Pharm. 2017, 527, 12–20. [CrossRef] [PubMed] 233. Rai, M.; Kon, K.; Ingle, A.; Duran, N.; Galdiero, S.; Galdiero, M. Broad-spectrum bioactivities of silver nanoparticles: The emerging trends and future prospects. Appl. Microbiol. Biotechnol. 2014, 98, 1951–1961. [CrossRef] [PubMed] 234. Hadrup,N.;Lam,H.R.Oraltoxicityofsilverions,silvernanoparticlesandcolloidalsilver—Areview.Regul. Toxicol. Pharmacol. 2014, 68, 1–7. [CrossRef] [PubMed] 235. Vazquez-Munoz, R.; Borrego, B.; Juarez-Moreno, K.; Garcia-Garcia, M.; Mota Morales, J.D.; Bogdanchikova, N.; Huerta-Saquero, A. Toxicity of silver nanoparticles in biological systems: Does the complexity of biological systems matter? Toxicol. Lett. 2017, 276, 11–20. [CrossRef] [PubMed] 236. Salarian,A.A.;Bahari,Y.;Hami,Z.;Soltani-Rezaee-Rad,M.Cephalexinnanoparticles:Synthesis,cytotoxicity and their synergistic antibacterial study in combination with silver nanoparticles. Mater. Chem. Phys. 2017, 198, 125–130. [CrossRef] 237. Stensberg,M.C.;Wei,Q.;McLamore,E.S.;Porterfield,D.M.;Wei,A.;Sepúlveda,M.S.Toxicologicalstudies on silver nanoparticles: Challenges and opportunities in assessment, monitoring and imaging. Nanomedicine 2011, 6, 879–898. [CrossRef] [PubMed] 238. MohamedElMahdy,M.;Salah,T.;SayedAly,H.;Mohammed,F.;Shaalan,M.Evaluationofhepatotoxicand genotoxic potential of silver nanoparticles in albino rats. Exp. Toxicol. Pathol. 2015, 67, 21–29. [CrossRef] [PubMed] 239. Pinzaru,I.;Coricovac,D.;Dehelean,C.;Moaca,E.A.;Mioc,M.;Baderca,F.;Sizemore,I.;Brittle,S.;Marti,D.; Calina, C.D.; et al. Stable peg-coated silver nanoparticles—A comprehensive toxicological profile. Food Chem. Toxicol. 2018, 111, 546–556. [CrossRef] [PubMed] 240. Jacob,J.A.;Sivalingam,P.;Chen,B.Toxicologicaleffectsofsilvernanoparticles.Environ.Toxicol.Pharmacol. 2015, 40, 729–732. 241. Franci,G.;Falanga,A.;Galdiero,S.;Palomba,L.;Rai,M.;Morelli,G.;Galdiero,M.Silvernanoparticlesas potential antibacterial agents. Molecules 2015, 20, 8856–8874. [CrossRef] [PubMed] 242. Wu,F.;Harper,B.J.;Harper,S.L.Differentialdissolutionandtoxicityofsurfacefunctionalizedsilvernanoparticles in small-scale microcosms: Impacts of community complexity. Environ. Sci. Nano 2017, 4, 359–372. [CrossRef] 243. Dubey,P.;Matai,I.;Kumar,S.U.;Sachdev,A.;Bhushan,B.;Gopinath,P.Perturbationofcellularmechanistic system by silver nanoparticle toxicity: Cytotoxic, genotoxic and epigenetic potentials. Adv. Colloid Interface Sci. 2015, 221, 4–21. [CrossRef] [PubMed] 244. Ribeiro,A.P.C.;Anbu,S.;Alegria,E.;Fernandes,A.R.;Baptista,P.V.;Mendes,R.;Matias,A.S.;Mendes,M.; Guedes da Silva, M.F.C.; Pombeiro, A.J.L. Evaluation of cell toxicity and DNA and protein binding of green synthesized silver nanoparticles. Biomed. Pharmacother. 2018, 101, 137–144. [CrossRef] [PubMed] 245. Lin,C.X.;Yang,S.Y.;Gu,J.L.;Meng,J.;Xu,H.Y.;Cao,J.M.Theacutetoxiceffectsofsilvernanoparticles on myocardial transmembrane potential, ina and ik1 channels and heart rhythm in mice. Nanotoxicology 2017, 11, 827–837. [CrossRef] [PubMed] 246. McShan,D.;Ray,P.C.;Yu,H.Moleculartoxicitymechanismofnanosilver.J.FoodDrugAnal.2014,22,116–127. [CrossRef] [PubMed]PDF Image | Biomedical Applications of Silver Nanoparticles
PDF Search Title:
Biomedical Applications of Silver NanoparticlesOriginal File Name Searched:
nanomaterials-08-00681-v2.pdfDIY PDF Search: Google It | Yahoo | Bing
Turbine and System Plans CAD CAM: Special for this month, any plans are $10,000 for complete Cad/Cam blueprints. License is for one build. Try before you buy a production license. More Info
Waste Heat Power Technology: Organic Rankine Cycle uses waste heat to make electricity, shaft horsepower and cooling. More Info
All Turbine and System Products: Infinity Turbine ORD systems, turbine generator sets, build plans and more to use your waste heat from 30C to 100C. More Info
CO2 Phase Change Demonstrator: CO2 goes supercritical at 30 C. This is a experimental platform which you can use to demonstrate phase change with low heat. Includes integration area for small CO2 turbine, static generator, and more. This can also be used for a GTL Gas to Liquids experimental platform. More Info
Introducing the Infinity Turbine Products Infinity Turbine develops and builds systems for making power from waste heat. It also is working on innovative strategies for storing, making, and deploying energy. More Info
Need Strategy? Use our Consulting and analyst services Infinity Turbine LLC is pleased to announce its consulting and analyst services. We have worked in the renewable energy industry as a researcher, developing sales and markets, along with may inventions and innovations. More Info
Made in USA with Global Energy Millennial Web Engine These pages were made with the Global Energy Web PDF Engine using Filemaker (Claris) software.
Infinity Turbine Developing Spinning Disc Reactor SDR or Spinning Disc Reactors reduce processing time for liquid production of Silver Nanoparticles.
| CONTACT TEL: 608-238-6001 Email: greg@infinityturbine.com | RSS | AMP |